Immunogenicity and safety of measles-mumps-rubella vaccine delivered by the aerosol, intradermal and intramuscular routes in previously vaccinated young adults: a randomized controlled trial protocol.
<h4>Background</h4>There are increasing reports of outbreaks of measles in countries that achieved measles elimination using two doses of measles-mumps-rubella (MMR) vaccine, particularly in health care settings. While responses to a third dose of MMR in two-dose recipients have been exa...
Saved in:
| Main Authors: | Sumanta Saha, Melanie Millier, Ari Samaranayaka, Liza Edmonds, Emma Best, James Ussher, Andrew Anglemyer, Jennifer Lee, Michael Tatley, Felicity Cutts, Rob van Binnendijk, Peter McIntyre |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2025-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0318893 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Gianotti–Crosti Syndrome Following Measles, Mumps, and Rubella Vaccination
by: Reena Rai, et al.
Published: (2025-01-01) -
Mumps antibody in the Thai population 17 years after the universal measles mumps rubella vaccination program
by: Varisara Ngaovithunvong, et al.
Published: (2016-08-01) -
Timing of Measles, Mumps, and Rubella Vaccination: Secondary Outcomes from an Immunological Survey
by: Jana Zibolenová, et al.
Published: (2025-04-01) -
MEASLES-MUMPS-RUBELLA VACCINATION IN A PAEDIATRIC TRANSPLANT PATIENT USING EVEROLIMUS
by: Aybüke Kaçır, et al.
Published: (2025-01-01) -
A review of safety and immunogenicity of a novel measles, mumps, rubella (MMR) vaccine
by: Nitin Shah, et al.
Published: (2024-12-01)